Literature DB >> 9382008

Role of inverted buttoned device in transcatheter occlusion of atrial septal defects or patent foramen ovale with right-to-left shunting associated with previously operated complex congenital cardiac anomalies.

P S Rao1, J S Chandar, E B Sideris.   

Abstract

Feasibility, safety, and effectiveness of transcatheter occlusion of atrial septal defect (ASD) with the buttoned device has been demonstrated. Despite its effectiveness in occluding secundum ASD with left-to-right shunt and patent foramina ovalia, presumably responsible for paradoxic embolism, it has limitations in effectively occluding ASD with evident right-to-left shunts. Therefore, the device was modified so that the square-shaped occluder component of the device is on the right atrial side, the inverted buttoned device. This study determines the feasibility, safety, and effectiveness of inverted buttoned device occlusion of atrial defects with right-to-left shunts. During a 17-month period ending August 1996, 12 patients, aged 1.6 to 39.0 years, underwent occlusion of residual ASD after repair of pulmonary atresia/stenosis with intact ventricular septum (n = 5), modified or fenestrated Fontan for tricuspid or pulmonary atresia (n = 5), and double-inlet left ventricle (n = 2). The systemic arterial oxygen saturation increased (p <0.001) from 82 +/- 7% (range 72% to 90%) to 94 +/- 3% (range 88% to 98%). There was no change in heart rate or cardiac index measured by Fick. Right atrial pressure increased by 1 to 4 mm in 5 of 12 patients (42%). There was trivial (n = 5) or no (n = 7) residual shunt by color Doppler study. Six- to 18-month (median 12) follow-up in all 12 patients revealed stable oxygen saturations (92 +/- 3%) by pulse oximetry. Color Doppler studies revealed small (n = 1), trivial (n = 1), or no (n = 10) residual shunt at follow-up. Based on these data, it is concluded that transcatheter occlusion of ASD with right-to-left shunts with inverted buttoned device is feasible in relieving arterial hypoxemia. Further clinical trials in a larger number of patients and careful evaluation of follow-up results are indicated to examine its safety and longer term effectiveness.

Entities:  

Mesh:

Year:  1997        PMID: 9382008     DOI: 10.1016/s0002-9149(97)00545-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Tricuspid Atresia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-12

Review 2.  Fontan Operation: Indications, Short and Long Term Outcomes.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2015-06-20       Impact factor: 1.967

3.  The Journey of an Indian Pediatric Cardiologist : Dr. K. C. Chaudhuri Lifetime Achievement Award/Oration at AIIMS, New Delhi, September 2017.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2017-09-27       Impact factor: 1.967

Review 4.  Consensus on timing of intervention for common congenital heart diseases: part I - acyanotic heart defects.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2012-06-30       Impact factor: 1.967

5.  Pulmonary Atresia with Intact Ventricular Septum.

Authors:  P. Syamasundar Rao
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-08

Review 6.  Consensus on timing of intervention for common congenital heart diseases: part II - cyanotic heart defects.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2013-05-03       Impact factor: 1.967

7.  Management of Congenital Heart Disease: State of the Art; Part I-ACYANOTIC Heart Defects.

Authors:  P Syamasundar Rao
Journal:  Children (Basel)       Date:  2019-03-08

Review 8.  Mitral Atresia with Normal Aortic Root.

Authors:  P Syamasundar Rao
Journal:  Children (Basel)       Date:  2022-07-30

Review 9.  Single Ventricle-A Comprehensive Review.

Authors:  P Syamasundar Rao
Journal:  Children (Basel)       Date:  2021-05-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.